Fukuyama congenital muscular dystrophy: Clinical features and therapeutic advances
Brain and Development · 2025-10 · 47 (5) · 104437
DOI: 10.1016/j.braindev.2025.104437 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Development, 2025-10. Verfasst von Keiko Ishigaki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Electronic addre…. Hauptthemen laut MEDLINE: Walker-Warburg Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: AMED, Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Electronic address: ishigaki.keiko@twmu.ac.jp.
- Department of Pediatrics, Kochi Medical School, Kochi University, Kohasu, Okoh-cho, Nankoku, Kochi 783-8505, Japan.
Förderung
- AMED
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
Zitieren
APA
Ishigaki, K., & Taniguchi-Ikeda, M. (2025). Fukuyama congenital muscular dystrophy: Clinical features and therapeutic advances. Brain and Development, 47(5), 104437. https://doi.org/10.1016/j.braindev.2025.104437
Vancouver
Ishigaki K, Taniguchi-Ikeda M. Fukuyama congenital muscular dystrophy: Clinical features and therapeutic advances. Brain and Development. 2025;47(5):104437. doi:10.1016/j.braindev.2025.104437
BibTeX
@article{Ishigaki2025,
author = {Ishigaki, Keiko and Taniguchi-Ikeda, Mariko},
title = {Fukuyama congenital muscular dystrophy: Clinical features and therapeutic advances},
journal = {Brain and Development},
year = {2025},
volume = {47},
number = {5},
pages = {104437},
doi = {10.1016/j.braindev.2025.104437}
}
EUVIMED